|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 5/065 | (2006.01) |
| C07K 5/02 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Number of the document | 3250237 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16705387.5 |
| Date of filing the European patent application | 2016-01-29 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation | 2021-09-27 |
| (86) | Number | PCT/US2016/015844 |
| Date | 2016-01-29 |
| (87) | Number | WO 2016/123582 |
| Date | 2016-08-04 |
| (30) | Number | Date | Country code |
| 201562110390 P | 2015-01-30 | US |
| (72) |
KLINE, Toni, US
YIN, Qun, US
BAJJURI, Krishna, US
|
| (73) |
Sutro Biopharma, Inc. ,
111 Oyster Point Blvd, South San Francisco CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Hemiasterlino junginiai, skirti konjugavimui ir gydymui |
| HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-12-18 | 11 | 289.00 EUR |
| 2027-01-29 |